Evaluation of Curcumin's effect on inflammation in hemodialysis patients

Summary Objective Despite advances in prevention of inflammatory milieu with different anti-inflammatory modalities in hemodialysis patients the rate of inflammatory markers in this population are still high. Inflammation is considered as a major player in uremia associated with morbidity and mortal...

Full description

Saved in:
Bibliographic Details
Published inClinical nutrition ESPEN Vol. 22; pp. 19 - 23
Main Authors Samadian, Fariba, Dalili, Nooshin, Poor -reza Gholi, Fatemeh, Fattah, Mahtab, Malih, Narges, Nafar, Mohsen, Firoozan, Ahmad, Ahmadpoor, Pedram, Samavat, Shiva, Ziaie, Shadi
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.12.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Summary Objective Despite advances in prevention of inflammatory milieu with different anti-inflammatory modalities in hemodialysis patients the rate of inflammatory markers in this population are still high. Inflammation is considered as a major player in uremia associated with morbidity and mortality in hemodialysis patients. The aim of this study was to evaluate the turmeric s effects on reduction of inflammatory markers in hemodialysis patients. Methods Hemodialysis patients over 18 years were recruited after fulfilling the inclusion criteria. Seventy-one hemodialysis patients were randomized into two groups: the trial group (n = 35) and the controls (n = 36); a randomization numeric table was used for allocation sequence. Trial group received turmeric and control group received placebo for 12 weeks. Biochemical determinations included levels of serum albumin (Alb), potassium (K), blood urea nitrogen (BUN), serum creatinine (Cr), IL-6 level, TNF-α, and liver function tests and hs-CRP at the start and end of the study were measured. Results Although there was a significant reduction in hs-CRP level, IL-6 level and TNF-α level in turmeric group (p = 0.002, p = 0.001, p = 0.001), there was no statistical difference between intervention and control groups. Albumin level was significantly increased in turmeric group (p = 0.001) and no meaningful changes were seen in potassium or liver function tests neither within nor between groups. Conclusion Programmed ingestion of turmeric has no adverse effects and reduces plasma level of hs-CRP, IL-6 and TNF-α accompanying with increases albumin levels in hemodialysis patients. Turmeric can be considered as an effective anti-inflammatory supplement in hemodialysis patients.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
ISSN:2405-4577
2405-4577
DOI:10.1016/j.clnesp.2017.09.006